ADAPTIMMUNE THERAPEUTICS PLC - AMERICAN DEPOSITARY

0.2581

04-April-25 16:45:00

15 minutes delayed

Stocks

-0.0658

-20.31%

Today's range

0.2500 - 0.3200

ISIN

N/A

Source

NASDAQ

NetDania - New 12 months Low: ADAPTIMMUNE THERAPEUTICS PLC - AMERICAN DEPOSITARY

01 Apr 2025 09:45:07 By NetDania Notify
NetDania - New 12 months Low: ADAPTIMMUNE THERAPEUTICS PLC - AMERICAN DEPOSITARY

31 Mar 2025 10:10:10 By NetDania Notify
NetDania - New 12 months Low: ADAPTIMMUNE THERAPEUTICS PLC - AMERICAN DEPOSITARY

28 Mar 2025 11:36:45 By NetDania Notify
NetDania - New 12 months Low: ADAPTIMMUNE THERAPEUTICS PLC - AMERICAN DEPOSITARY

27 Mar 2025 16:14:59 By NetDania Notify
NetDania - New 12 months Low: ADAPTIMMUNE THERAPEUTICS PLC - AMERICAN DEPOSITARY

26 Mar 2025 09:52:29 By NetDania Notify
NetDania - New 12 months Low: ADAPTIMMUNE THERAPEUTICS PLC - AMERICAN DEPOSITARY

25 Mar 2025 10:18:57 By NetDania Notify
NetDania - New 12 months Low: ADAPTIMMUNE THERAPEUTICS PLC - AMERICAN DEPOSITARY

20 Mar 2025 09:45:04 By NetDania Notify
NetDania - New 12 months Low: ADAPTIMMUNE THERAPEUTICS PLC - AMERICAN DEPOSITARY

11 Mar 2025 09:45:12 By NetDania Notify
NetDania - New 12 months Low: ADAPTIMMUNE THERAPEUTICS PLC - AMERICAN DEPOSITARY

10 Mar 2025 11:09:08 By NetDania Notify
NetDania - New 12 months Low: ADAPTIMMUNE THERAPEUTICS PLC - AMERICAN DEPOSITARY

04 Mar 2025 09:45:41 By NetDania Notify
NetDania - New 12 months Low: ADAPTIMMUNE THERAPEUTICS PLC - AMERICAN DEPOSITARY

28 Feb 2025 14:31:25 By NetDania Notify
NetDania - New 12 months Low: ADAPTIMMUNE THERAPEUTICS PLC - AMERICAN DEPOSITARY

25 Feb 2025 11:38:59 By NetDania Notify
NetDania - New 12 months Low: ADAPTIMMUNE THERAPEUTICS PLC - AMERICAN DEPOSITARY

31 Dec 2024 10:11:59 By NetDania Notify
NetDania - New 12 months Low: ADAPTIMMUNE THERAPEUTICS PLC - AMERICAN DEPOSITARY

26 Dec 2024 11:12:55 By NetDania Notify
Preclinical Proof-of-Concept Data Supporting Future Clinical Development of Two New Cell Therapies Being Presented by Adaptimmune at ASGCT

16 May 2022 17:00:00 By Nasdaq GlobeNewswire
Adaptimmune Reports First Quarter Financial Results and Business Update

09 May 2022 07:30:00 By Nasdaq GlobeNewswire
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer

04 May 2022 08:00:00 By Nasdaq GlobeNewswire
Adaptimmune to Report Q1 2022 Financial Results and Business Updates on Monday, May 9, 2022

28 Apr 2022 16:30:00 By Nasdaq GlobeNewswire
Adaptimmune Presents MAGE-A4 Expression Data from its Screening Protocol at AACR Confirming Expression Across a Broad Range of Solid Tumors

08 Apr 2022 13:00:00 By Nasdaq GlobeNewswire
Adaptimmune to Report Q4 and Full Year 2021 Financial Results and Business Updates on Monday, March 14, 2022

08 Mar 2022 12:35:58 By Nasdaq GlobeNewswire

<<
<
1
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.